Main navigation

Home
Breaking News & Opinion
Chapters
Regions
Topics
About Us
Privacy

Home
national survey on drug use and health

national survey on drug use and health

Share

Chapters

AIDS and HIV
Addiction and Dependence
Adolescents and Substance Use
Alcohol
Amphetamine-Type Stimulants
Arrests and Law Enforcement
Buprenorphine
Cannabis
Capital Punishment
Causes of Death
CBD (Cannabidiol)
Chronic Pain
Civil Rights
Cocaine and Crack
Corruption
Crime
Dark Web Drug Markets and Cryptomarkets
Death Penalty
Demand Reduction
Diversion of Prescription Drugs
Driving and Substance Use
Drug and Alcohol Use Testing Overview
Drug Checking Services / Drug Checking for Contaminants
Drug Consumption Rooms
Drug Courts
Drug Policies and Policy Reform
Drug Use Estimates: Prevalence and Trends
Drug Use Testing Related To Employment
Drug Use Testing Related To Schools
Drugs and Prison
Drugs and the Carceral System
Economics
Ecstasy (MDMA)
Entheogens and Psychedelics
Environment
Families
Fentanyl
Forfeiture
Gateway Hypothesis
Harm Reduction
Harm Reduction Service Programs
Hemp
Hepatitis C
Heroin
Heroin Treatment
HIV and People Who Inject Drugs
HIV, Race, and Injection Drug Use
Human Enhancement Drugs
Ibogaine
Image and Performance Enhancing Drugs (IPEDS)
Interdiction
International
Jails
Ketamine
Kratom
Mandatory Minimums
Marijuana
Marijuana Policy
MDMA (Ecstasy
Medical Marijuana
Medications for Opioid Use Disorder
Mental Health and Substance Use
Mental Health Medications
Methadone
Methamphetamine
Militarization
Mushrooms (Psilocybin)
Naloxone
Needle Exchange
Netherlands vs US
Nicotine Products
Nitazenes
Novel Psychoactive Substances
Overdose
Overdose Crisis
Overdose Prevention
Pain Management
People Who Inject Drugs (PWID)
Performance and Image Enhancing Drugs (PIEDS)
Pregnancy
Prevalence of Substance Use
Prevention
Prisons, Jails, Probation, and Parole
Prisons and Drug Offenders
Psilocybin
Race and Prisons
Recovery
Safe Consumption Sites
Safe Supply / Safer Supply Programs
Safer Smoking / Safer Smoking Kits
Steroids
Supply Reduction
Substance Use Disorders
Supervised Consumption Sites
Syringe Exchange
Syringe Service Programs
Tobacco
Treatment
Vivitrol (Naltrexone)
Women
Xylazine
Young People and Substance Use

Topics

Demand Reduction
Harm Reduction
Special Populations
Special Topics
Substances
Supply Reduction

Regions Outside U.S.

Australia
Austria
Belgium
Canada
Central Asia and Eastern Europe
Colombia
Denmark
European Union
France
Germany
Greece
Hungary
Ireland
Mexico
Netherlands
Norway
Portugal
Russia
Scotland
Spain
Sweden
Switzerland
Ukraine
United Kingdom